Qualigen Therapeutics, Inc. Appoints Tariq Arshad, MD, MBA as Chief Medical Officer

Ads

You May Also Like

PCI Biotech: Fourth quarter and preliminary 2016 results

Oslo, 28 February 2017 - Please find enclosed the financial report and presentation for ...

Onxeo Announces Top-Line Results from ReLive Phase III Study of Livatag® in Advanced Hepatocellular Carcinoma

PARIS, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Paris:ONXEO) (NASDAQ Copenhagen:ONXEO), (“Onxeo” ...

StoneCalibre Affiliate Acquires In-Vitro Diagnostics Products Provider Alpha-Tec Systems

StoneCalibre Affiliate Acquires In-Vitro Diagnostics Products Provider Alpha-Tec Systems Industry: Life Sciences LOS ANGELES, ...